Hyperbaric oxygen therapy (HBOT) does change your blood pressure, and for most people the change is upward, not down. The shift is usually small, temporary, and gone within minutes of leaving the chamber, but it is real, it is measurable, and it matters more for some people than others. This article walks through what actually happens to your heart and blood vessels inside a hyperbaric chamber, what the published numbers look like, and where the evidence is solid versus thin.
The short version of what happens to your cardiovascular system
When you breathe 100% oxygen at pressures above sea level, your blood vessels tighten. That tightening raises the resistance your heart has to push against, which nudges your blood pressure up. Your body senses the higher pressure and responds by slowing your heart rate down. So inside the chamber you tend to see two things at once: blood pressure goes up a bit, and heart rate drops a bit.
This is not a side effect that went unnoticed and is only now being studied. It is a well-described, predictable response to high-dose oxygen, documented across decades of hyperbaric medicine. The open questions are about how much it matters for people who already have heart disease, high blood pressure, or heart failure, and that is where the honest answer gets more careful.
Does HBOT raise blood pressure? The direct evidence
Yes, on average it does. The clearest data come from a 2020 retrospective study that measured blood pressure before and after thousands of individual HBOT sessions.
The researchers tracked 108 patients across 3,291 sessions, with most patients doing about 30 sessions each. After a session, blood pressure rose by a consistent, statistically significant amount.
| Measurement | Average change after HBOT | 95% confidence interval |
|---|---|---|
| Systolic (top number) | +11.3 mmHg | 10.3 to 12.3 |
| Mean arterial pressure | +6.6 mmHg | 6.0 to 7.2 |
| Diastolic (bottom number) | +4.3 mmHg | 3.7 to 4.8 |
An 11 mmHg jump in the top number is not trivial, but it is also not dangerous for most people. To put it in context, that is roughly the difference between walking up a flight of stairs and standing still. The bigger story is in who shows the biggest swings.
People with existing high blood pressure react more
The same study found that your history matters a lot. Patients with a known history of hypertension saw their systolic pressure climb by about 13.6 mmHg on average. Patients with no hypertension history barely moved, at about 2.5 mmHg.
That gap is the single most useful takeaway from the data. If your blood pressure is already high or you take medication for it, your body responds more strongly to the oxygen and pressure than someone with normal blood pressure does.
How often does it spike to a scary level?
Rarely, but not never. Out of those 3,291 sessions, 151 sessions (about 4.6%) pushed systolic pressure above 180 mmHg, the threshold often called hypertensive crisis. Only 3 sessions (0.09%) pushed diastolic above 120 mmHg.
Here is the reassuring part the authors emphasized: every one of those patients was symptom-free, and their blood pressure drifted back to normal on its own within a few minutes, with no treatment needed. So while the numbers can briefly look alarming on a monitor, they did not translate into emergencies in this group. The practical lesson the researchers drew was simple: check blood pressure before each session and watch the people who start high more closely.
The mechanism, in plain terms
To understand why your blood pressure goes up while your heart slows down, it helps to follow the chain of events. This is one of the more genuinely well-understood parts of hyperbaric physiology.
Step one: oxygen tightens your blood vessels
Under normal conditions, the lining of your blood vessels (the endothelium) makes a molecule called nitric oxide, which keeps vessels relaxed and open. When you flood your blood with oxygen at high pressure, you also flood it with reactive oxygen molecules. Those molecules chew up nitric oxide before it can do its relaxing job.
Less nitric oxide means less relaxation, which means the vessels tighten. This is called hyperoxic vasoconstriction. Some research suggests nitric oxide availability can drop dramatically under these conditions. A few other players pitch in too: vessel-tightening compounds like endothelin-1 go up, and vessel-relaxing prostaglandins go down. The net effect is narrower arteries and higher resistance.
Step two: tighter vessels raise blood pressure
When your arteries narrow, your heart has to push against more resistance to move blood. That extra resistance is what shows up as a higher reading on the cuff. Doctors call this increased "afterload."
Step three: your body slows the heart to compensate
Pressure sensors in your neck and chest, called baroreceptors, notice the rising pressure. They send a signal that tells your heart to slow down, working through the vagus nerve and your parasympathetic ("rest and digest") nervous system.
One detailed study captured this with real numbers. During a session, systolic pressure rose from 115 to 148 mmHg and diastolic from 62 to 81 mmHg (both about a 31% rise), while heart rate fell from about 72 to 64 beats per minute. Importantly, the researchers showed the heart slowing happened after and because of the pressure rise, not directly from the oxygen. The bradycardia is a reflex, not a poison effect.
| What happens | Direction | Why |
|---|---|---|
| Blood vessels | Tighten | Oxygen destroys nitric oxide, the "relax" signal |
| Systemic vascular resistance | Up | Narrower vessels resist blood flow |
| Blood pressure | Up | Heart pushes against higher resistance |
| Heart rate | Down | Baroreceptor reflex via the vagus nerve |
| Cardiac output | Often down slightly | Slower heart plus higher afterload |
Why this is usually protective, not harmful
It is worth naming something the research stresses: hyperoxic vasoconstriction is widely viewed as a counterbalance response, a built-in brake the body applies against being flooded with too much oxygen. By tightening vessels, your body limits how much extra oxygen reaches the tissues, which protects against oxygen overload. So the same mechanism that nudges your blood pressure up is also doing a job. That framing helps explain why, in healthy people, the cardiovascular changes rarely cause problems even across 30 or 40 sessions. The system is regulating itself, not breaking down.
The timing also reassures. In the detailed study that tracked second-by-second changes, oxygen levels in the tissue shot up fast, but the heart rate slowed gradually. That lag is the signature of a reflex catching up to a stimulus, exactly what you would expect from a baroreceptor response rather than a direct toxic hit on the heart. Once you decompress and breathe normal air again, the stimulus disappears and your numbers drift back.
Is this dangerous? Honest grading of the evidence
For a healthy adult or a typical patient getting HBOT for a wound, the cardiovascular changes are mild and self-correcting. The evidence here is strong and consistent: blood pressure goes up modestly, heart rate goes down, and both normalize quickly. There is no good evidence that routine HBOT damages a healthy heart.
The picture gets murkier and more cautious for two specific groups: people with heart failure and people with severe coronary disease. Here the evidence is thinner, mostly drawn from small studies and case reports, and it deserves a careful read rather than a confident headline.
Heart failure: the real concern, but smaller than feared
The worry is logical. HBOT tightens vessels (raising afterload) and can slightly lower cardiac output. A weakened heart that already struggles to pump against resistance might tip into pulmonary edema, where fluid backs up into the lungs. For years this kept HBOT on the "relatively contraindicated" list for people with reduced ejection fraction.
A 2024 retrospective cohort study put some numbers on this. Researchers followed 23 heart failure patients through 906 HBOT sessions. The breakdown:
- 13 patients with preserved ejection fraction (HFpEF)
- 3 with mid-range ejection fraction
- 7 with reduced ejection fraction (HFrEF)
Two of the 23 patients (about 9%) developed pulmonary edema. One was a patient with very low ejection fraction (24%) who had skipped his diuretic before treatment; he was managed as an outpatient and finished 33 sessions. The other had preserved ejection fraction but needed a hospital admission and chose to stop. The other 21 patients completed treatment without any heart complications.
The honest read: HBOT can push a fragile heart into fluid overload, and that risk is real for people with reduced ejection fraction. But with their heart medications optimized, fluid intake managed, and close monitoring, most heart failure patients in this small study tolerated treatment fine. This is a small cohort, not a randomized trial, so treat it as encouraging rather than definitive.
Coronary artery disease and atherosclerosis
For people with narrowed coronary arteries, the concern is that hyperoxic vasoconstriction could reduce blood flow to heart muscle that is already getting too little. The mechanism is plausible, and reviews of hyperbaric cardiovascular physiology recommend extra caution and monitoring for patients with significant atherosclerosis, especially those who also have diabetes. But there is no large body of evidence showing that supervised HBOT triggers heart attacks in these patients. It is a theoretical risk that justifies screening and supervision, not a proven hazard.
There is a counterpoint worth knowing too. Although oxygen narrows blood vessels, the sheer amount of oxygen dissolved in the blood plasma during HBOT is enormous, far more than red blood cells normally carry. So even with tighter vessels, tissue oxygen delivery generally stays high. This is part of why HBOT is used at all: it forces oxygen into tissues that are starved for it. The cardiovascular tightening and the oxygen flooding happen at the same time, and for most patients the oxygen benefit dominates. The catch is that this calculus is different for a heart that cannot tolerate extra workload, which is exactly why heart failure and unstable coronary disease get singled out.
What about diabetes and other conditions?
People with diabetes are common in HBOT clinics because the therapy is a standard, evidence-backed treatment for diabetic foot ulcers. Many of these patients also have high blood pressure, atherosclerosis, and stiffer blood vessels, so they sit in a higher-attention group for cardiovascular monitoring. Reviews specifically call out diabetic and atherosclerotic patients as the ones to watch most closely. This is not a reason to avoid HBOT, since the wound-healing benefit is real and well-documented, but it is a reason to make sure your clinic checks your numbers and knows your full history. Blood sugar can also dip during sessions, which is a separate issue your clinic should manage but worth raising in the same conversation.
How the cardiovascular response stacks up against the other risks
It helps to see blood pressure in the context of HBOT's broader safety profile. A 2023 systematic review and meta-analysis pooled 24 randomized trials and 1,497 patients. It found HBOT groups reported more side effects than control groups (30% versus 10%), but the most common problems were not cardiovascular.
| Side effect | How common | Severity |
|---|---|---|
| Ear discomfort / barotrauma | Most common (113 cases) | Usually mild, manageable |
| Vision changes (temporary nearsightedness) | Second most common | Reversible, resolves over weeks |
| Blood pressure rise | Common, modest | Mild, self-correcting |
| Pulmonary edema (heart failure patients) | Rare | Serious, needs monitoring |
| Oxygen toxicity seizure | Very rare | Serious but transient |
The review also flagged two patterns worth knowing: higher chamber pressures (2.0 ATA and above) carried more side effects, and longer courses (over 10 sessions) carried more too. That tracks with what you would expect, since a bigger oxygen dose drives a bigger physiologic response. Notably, congestive heart failure showed up in only two of the trials and was not statistically more common in HBOT groups, though the reviewers still advised caution in heart failure patients.
This dose-response pattern is also why the so-called "mild" hyperbaric chambers running at 1.3 ATA produce a gentler cardiovascular response than hospital-grade chambers at 2.0 to 2.4 ATA. Less pressure and a lower oxygen concentration mean less vasoconstriction and a smaller blood pressure bump. That does not make mild chambers automatically "better" for the heart, since the lower dose also means a weaker therapeutic effect for the conditions HBOT actually treats. It just means the cardiovascular response scales with the dose, and your blood pressure response at 2.4 ATA on 100% oxygen will be larger than at 1.3 ATA on a lower oxygen fraction.
One more piece of context on the meta-analysis: the higher side-effect rate in HBOT groups (30% versus 10%) sounds dramatic, but it is driven overwhelmingly by mild, expected, reversible problems like ear pressure and temporary vision shifts. Serious cardiovascular events were rare across all 1,497 patients. The takeaway is not that HBOT is risky for the heart in general, but that the modest, predictable cardiovascular response is one item on a list of mostly minor effects, with the genuinely serious cardiac risk concentrated in a small, identifiable group of patients.
Who should think twice, and who can relax
Most people getting HBOT do not need to worry about their heart or blood pressure. The cardiovascular response is built into how the therapy works and rarely causes trouble. That said, some people should make sure their care team knows their history.
Talk to your doctor first if you:
- Have heart failure, especially with a reduced ejection fraction
- Have poorly controlled high blood pressure
- Have significant coronary artery disease or have had a recent heart attack
- Take blood pressure medication and have unstable readings
- Have an implanted cardiac device (discuss chamber compatibility)
You can generally relax if you:
- Have normal blood pressure and no heart disease
- Have well-controlled hypertension on stable medication
- Are getting HBOT for a wound, infection, or other standard indication under medical supervision
The single best protective step is supervision. A reputable hyperbaric center checks your blood pressure before each session, knows your cardiac history, and watches the higher-risk patients closely. That is the difference between a managed, predictable physiologic response and an unmonitored gamble. If you are weighing a facility, our guide on how to find a legitimate HBOT clinic near you covers what to look for.
Practical questions worth asking before you start
If you have any cardiovascular concern, a few specific questions can tell you a lot about whether a clinic is doing things right:
- Do you take my blood pressure before every session?
- What is my baseline, and at what reading would you delay or stop a session?
- Have you treated patients with my condition before?
- Is there a physician on site or on call during treatments?
- How will you coordinate with my cardiologist?
A clinic that answers these clearly and without defensiveness is a good sign. For a fuller list, see our 15 questions to ask before starting HBOT. And if you want the wider safety picture beyond the heart, our HBOT side effects and risks guide and our breakdown of when HBOT is genuinely dangerous go deeper. To understand how chamber pressure drives the dose, our explainer on HBOT pressure: 1.3 vs 2.0 vs 2.4 ATA is a useful companion.
Frequently Asked Questions
Does HBOT permanently raise your blood pressure?
No. The rise is temporary. Blood pressure climbs modestly during and right after a session, then returns to your baseline within minutes once you leave the chamber. There is no good evidence that a course of HBOT permanently increases blood pressure in people with healthy hearts. People with existing hypertension show larger temporary swings, which is why pre-session monitoring matters.
Can I do HBOT if I take blood pressure medication?
Usually yes, if your blood pressure is well controlled and stable. Tell your hyperbaric team about every medication you take and your typical readings. A good clinic checks your pressure before each session and has a threshold at which they will delay treatment. Do not stop or skip your blood pressure medication around treatment unless your doctor tells you to. The same goes for diuretics if you have heart failure, since skipping one was a factor in a documented case of fluid overload.
Is HBOT safe if I have heart failure?
It can be, with the right precautions, but it carries more risk than for the average patient. The main danger is pulmonary edema, where the higher afterload from vessel tightening overwhelms a weak heart and fluid backs up into the lungs. In a 2024 study of 23 heart failure patients, 2 developed pulmonary edema, but 21 completed treatment safely when their heart medications and fluid balance were optimized first. Reduced ejection fraction calls for the most caution. This is a conversation to have with both your cardiologist and the hyperbaric physician.
Why does my heart rate drop in the chamber?
Because of a reflex, not because the oxygen is harming your heart. The high-dose oxygen tightens your blood vessels and raises your blood pressure. Pressure sensors in your neck and chest detect that rise and signal your heart to slow down to compensate, working through the vagus nerve. In one study, heart rate fell from about 72 to 64 beats per minute as pressure climbed. It is a normal, protective response and reverses after the session.
How much does HBOT actually raise blood pressure?
On average, systolic (top number) pressure rises about 11 mmHg and diastolic (bottom number) about 4 mmHg right after a session, based on a study of over 3,000 sessions. People with a history of high blood pressure see larger jumps, around 13 to 14 mmHg systolic, while people with normal pressure barely move, around 2 to 3 mmHg. Brief spikes above 180 systolic happened in under 5% of sessions, were symptom-free, and resolved on their own within minutes.
This article is for general information only and is not medical advice. HBOT affects your cardiovascular system, and decisions about treatment should be made with a qualified physician who knows your heart and blood pressure history.
Sources
- Magnitude and Clinical Predictors of Blood Pressure Changes in Patients Undergoing Hyperbaric Oxygen Therapy: A Retrospective Study (IJERPH, 2020)
- Hyperoxia and the cardiovascular system: experiences with hyperbaric oxygen therapy (Medical Gas Research, 2022)
- Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study (PLoS One, 2024)
- Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis (Frontiers in Medicine, 2023)
- Hyperbaric Cardiovascular Effects (StatPearls, NCBI Bookshelf)
- FDA: Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices — Letter to Health Care Providers
- UCLA Health: Hyperbaric Medicine Indications
- PubMed search: hyperbaric oxygen therapy cardiovascular effects
- PubMed search: hyperbaric oxygen therapy heart failure pulmonary edema